Follow The Filings

BMRA Biomerica

Biomerica earnings company data as of 7:22 PM ET 10/16

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2027 Q1 13 Oct EPS — -0.37 —
Rev — — —
FY2026 Q2 4 Sep EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by BMRA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BMRA insider trades
  • $158K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. M. Huff Gary Director
    Buy
    $50K 31,250 shares at $1.60 +156% to stake
    Traded Aug 20 Filed Aug 27
    ↗
  2. David Moatazedi Director
    Buy
    $16K 10,000 shares at $1.60 +33% to stake
    Traded Aug 26 Filed Aug 27
    ↗
  3. Eric Chin Director
    Buy
    $10K 6,250 shares at $1.60 +19% to stake
    Traded Aug 26 Filed Aug 27
    ↗
  4. Allen Barbieri Executive Vice Chairman
    Buy
    $32K 20,000 shares at $1.60 +37% to stake
    Traded Aug 26 Filed Aug 27
    ↗
  5. Zackary S. Irani CEO
    Buy
    $50K 31,250 shares at $1.60 +15% to stake
    Traded Aug 26 Filed Aug 27
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 stock grants.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
DEF 14A Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
10-K/A Filing Doc
10-K Filing Doc
SCHEDULE 13D — Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
10-Q Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-K/A Filing Doc
10-K Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 3.03,5.03,7.01,9.01 Filing Doc
10-Q Period Feb 28, 2025 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Period Nov 30, 2024 Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.